Cargando…

Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease

INTRODUCTION: Alpha-synucleinopathy constituting a characteristic feature of Parkinson’s disease (PD) occurs at all levels of the brain-gut axis including the enteric nervous system (ENS). Lesions in the ENS may be connected with gut inflammation, increased intestinal permeability and dysmotility co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulak, Agata, Koszewicz, Magdalena, Panek-Jeziorna, Magdalena, Koziorowska-Gawron, Ewa, Budrewicz, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776883/ https://www.ncbi.nlm.nih.gov/pubmed/31611762 http://dx.doi.org/10.3389/fnins.2019.00992

Ejemplares similares

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
por: Koszewicz, Magdalena, et al.
Publicado: (2021)

An Inverse Correlation of Serum Fibroblast Growth Factor 19 with Abdominal Pain and Inflammatory Markers in Patients with Ulcerative Colitis
por: Panek-Jeziorna, Magdalena, et al.
Publicado: (2020)

Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report
por: Koziorowska-Gawron, Ewa, et al.
Publicado: (2021)

Parry–Romberg syndrome: clinical, electrophysiological and neuroimaging correlations
por: Budrewicz, Sławomir, et al.
Publicado: (2011)

The possible meaning of fractional anisotropy measurement of the cervical spinal cord in correct diagnosis of amyotrophic lateral sclerosis
por: Budrewicz, Slawomir, et al.
Publicado: (2015)

The Use of Quantitative Sensation Testing to Identify the Physiological Differences Between the Median and Ulnar Nerves
por: Koszewicz, Magdalena, et al.
Publicado: (2021)

Correlations between Electrophysiological Parameters, Lymphocyte Distribution and Cytokine Levels in Patients with Chronic Demyelinating Inflammatory Polyneuropathy
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders
por: Dziadkowiak, Edyta, et al.
Publicado: (2022)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications
por: Dziadkowiak, Edyta, et al.
Publicado: (2023)

Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease
por: Dumitrescu, Laura, et al.
Publicado: (2021)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
por: Hor, Jia Wei, et al.
Publicado: (2022)

N°39 – Fulminant life-threatening myopathy of the genetic origin
por: Budrewicz, Slawomir, et al.
Publicado: (2023)

Is nigrostriatal dopaminergic deficit necessary for Holmes tremor to develop? The DaTSCAN and IBZM SPECT study
por: Gajos, Agata, et al.
Publicado: (2017)

The Usefulness of Quantitative EEG and Advanced MR Techniques in the Monitoring and Long-Term Prognosis of Lance-Adams Syndrome
por: Szczepańska, Aleksandra, et al.
Publicado: (2019)

The Relevance of Collision Tests and Quantitative Sensory Testing in Diagnostics and Postoperative Outcome Prediction in Carpal Tunnel Syndrome
por: Koszewicz, Magdalena, et al.
Publicado: (2022)

Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease
por: Singh, Yogesh, et al.
Publicado: (2019)

Eight Weeks of Aerobic Interval Training Improves Psychomotor Function in Patients with Parkinson’s Disease—Randomized Controlled Trial
por: Marusiak, Jarosław, et al.
Publicado: (2019)

Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)

Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
por: Shokri-Afra, Hajar, et al.
Publicado: (2021)

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
por: Hamberg, Viggo, et al.
Publicado: (2022)

Is peripheral paraneoplastic neurological syndrome possible in primary brain tumors?
por: Koszewicz, Magdalena, et al.
Publicado: (2016)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy
por: Dziadkowiak, Edyta, et al.
Publicado: (2023)

Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2020)

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders
por: Moorman, Erin L., et al.
Publicado: (2021)

Fecal Calprotectin Elevations Associated with Food Intolerance/Malabsorption Are Significantly Reduced with Targeted Diets
por: Schnedl, Wolfgang J., et al.
Publicado: (2023)

Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Validity and reliability of the Polish version of the Michigan Neuropathy Screening Instrument
por: Sutkowska, Edyta, et al.
Publicado: (2023)

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
por: Barbosa, Jéssica A., et al.
Publicado: (2021)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Systematic review on fecal calprotectin in cystic fibrosis
por: Lazzarotto, Eduarda Sampaio, et al.
Publicado: (2022)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
por: Bustinduy, Amaya L., et al.
Publicado: (2013)

Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
por: Mulak, Agata
Publicado: (2021)

The Relationship between Occupationally Exposed Arsenic, Cadmium and Lead and Brain Bioelectrical Activity—A Visual and Brainstem Auditory Evoked Potentials Study
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_em8skhb8gmdnaq3tlml0q1s4pu